The first question every patient asks: "Are the clinics as good?" It's the right question. And the honest answer is more nuanced than either "yes, identical" or "no, stick with the U.S." Here's how to actually compare IVF outcomes between Colombian clinics and American programs — and why the comparison isn't as straightforward as it looks.
The SART Problem
In the United States, IVF clinics report outcomes to the Society for Assisted Reproductive Technology (SART) and the CDC. This creates a publicly searchable database where you can compare live birth rates by age group, fresh vs. frozen cycles, and donor vs. own-egg cycles. It's the most transparent fertility reporting system in the world.
Colombia doesn't have an equivalent national reporting mandate. Some Colombian clinics publish outcomes voluntarily, but there's no centralized database where patients can cross-reference claims. This is a real limitation, not something to paper over.
What the U.S. Data Actually Shows
These numbers represent national averages across 450+ U.S. clinics. The best U.S. programs — CCRM, RMA, Shady Grove — report rates 5–15 percentage points above these averages for patients under 40. The weakest U.S. programs fall below.
Colombian clinics serving international patients generally report outcomes comparable to the U.S. national average, with some quoting rates above average for specific age cohorts. But without mandatory external verification, these numbers carry an asterisk.
How to Evaluate a Colombian Clinic
| What to Ask | Why It Matters | Red Flag |
|---|---|---|
| Live birth rate by age group (own eggs) | Raw pregnancy rates mean nothing without age stratification | Clinic quotes a single rate across all ages |
| Pregnancy rate per transfer vs per cycle started | Per-transfer rates look better; per-cycle-started is the honest number | They don't understand the distinction |
| Freeze-all vs fresh transfer rates | Different protocols, different denominators | Clinic doesn't track separately |
| Number of cycles performed annually | Volume = experience; <100 IVF cycles/year is low | Won't disclose cycle volume |
| Lab equipment and embryo culture system | Time-lapse incubators, air filtration, QA protocols | Can't specify equipment brands |
| Embryologist credentials | Senior embryologists with international training | No embryologist on the team (doctor does everything) |
The Apples-to-Oranges Problem
Even when you have data from both countries, comparison is tricky because patient populations differ. U.S. SART data includes every patient — including the most challenging cases that high-volume U.S. centers accept. Colombian clinics serving medical tourists may see a different demographic: patients who've self-selected for travel, potentially healthier on average, potentially younger.
This selection bias can make Colombian clinic data look artificially strong relative to U.S. national averages. It's not fraud — it's demographics. A fair comparison requires matching by age, diagnosis, and protocol, which no public database currently enables cross-border.
Want Help Evaluating Clinic Data?
We'll help you interpret Colombian clinic outcome reports and compare them fairly to SART benchmarks — so you can make an informed decision based on real numbers.
Chat on WhatsApp